Most conversations about building performance focus on comfort, cost or carbon. In life sciences real estate, the stakes are considerably higher. That was the backdrop to our conversation with Dan Pagella, Senior Director of Asset Management at ARC, on the new season of Built to Perform.
Dan puts it plainly: “people could die if we get it wrong, but equally, if we get it right, we could save lives.” A power failure or a gas line issue in a lab building isn’t an inconvenience, it can write off months of research and cost tens of thousands of pounds in the process.
Why flexibility matters more than the occupier
That level of risk changes how Dan thinks about investment. His comparison is a simple one: “no one investing in a hotel asks who’s in room 103 on a Tuesday.” Real estate built around flexibility, in his view, needs to be valued as a platform rather than judged by occupier by occupier.
He backs that argument with a concrete example, a plain English lease running to nine pages can be signed on the spot, with an occupier on board the next day. The alternative is a 40-page lease that takes months to negotiate, followed by a 120-day wait just to get broadband connected. The gap between those two outcomes isn’t about legal complexity. It’s about how much flexibility an operator is willing to build into their own process.
Making the business case for building tech
Dan is just as direct when the conversation turns to building technology. He wants operational performance that occupiers never have to think about: buildings that simply run properly in the background, with fewer site visits chasing faults and fewer complaints about hot and cold spots. And when it comes to making the business case to a CFO, the argument is straightforward: cut the energy bill by 25% and people understand it immediately.
He credits IBOS for taking that burden off his building managers, describing the difference between staff spending their lives chasing problems, and a system that simply flags them before they escalate. It’s a conversation that makes a strong case for the same operational discipline being applied well beyond life sciences.
